You are here: Industry Insights > GSK

News List

GSK Pharmaceuticals’ revenue grows at seven per cent in Q1 expresspharma
July 25, 2019
GlaxoSmithKline Pharmaceuticals has declared its financial results for the quarter ended 30th June 2019. Revenue for the quarter came in at Rs 788 crores, an increase of seven per cent over the same period last year.
GSK Ships 2019-20 Seasonal Influenza Vaccines for US Market americanpharmaceuticalreview
July 17, 2019
GSK will begin shipping its quadrivalent influenza vaccines to US healthcare providers and pharmacies for the 2019-20 flu season, immediately following licensing and lot-release approval from the US Food and Drug Administration's (FDA) Center for Biologic
EC approves GSK-Pfizer consumer health JV with conditions pharmaceutical-technology
July 12, 2019
The European Commission (GSK) has cleared GlaxoSmithKline (GSK) and Pfizer’s proposed merger of respective consumer health businesses to create a joint venture (JV).
GSK’s Dovato suppresses AIDS virus at same levels of three-drug regimen expresspharma
July 11, 2019
GlaxoSmithKline Plc’s two-drug HIV regimen Dovato was successful in suppressing the AIDS-causing virus in patients for six months at the same level of a previous three-drug treatment in a late-stage study, the drugmaker said on Wednesday.
GSK Opens Two Mfg. Facilities in Singapore contractpharma
July 10, 2019
Invests $95 million for continuous manufacturing to shorten timelines to produce daprodustat.
GSK opens new pharma manufacturing facilities with S$130M investment biospectrumasia
July 08, 2019
New digital technology facilities and expansion of production building will boost capabilities to accelerate the supply and production of APIs for clinical trial
GSK taps NASCAR favorite to drive awareness of new Nicorette lozenge fiercepharma
July 04, 2019
NASCAR driver Dale Earnhardt Jr. is taking the wheel for GlaxoSmithKline’s new Nicorette innovation—a better-tasting ice mint lozenge.
SpringWorks and GSK sign clinical trial collaboration agreement pharmaceutical-technology
July 01, 2019
SpringWorks Therapeutics has signed an agreement to assess its nirogacestat in combination with GlaxoSmithKline’s (GSK) belantamab mafodotin to treat patients with relapsed or refractory multiple myeloma.
GSK and Regional Centre for Biotechnology to develop PhD programs in biostatistics and… expressbpd
June 28, 2019
The programme cover scholarship and expert guidance for completion of doctoral degrees programs to equip students with high-end expertise to boost biopharma research for India and the world
GSK wins speedy FDA Zejula review in ovarian cancer niche fiercepharma
June 28, 2019
GlaxoSmithKline has been working to restrengthen in cancer, particularly through a multibillion-dollar purchase of Tesaro. The main drug from the buyout, Zejula, is now up for a priority review in late-stage ovarian cancer, which the company hopes will he

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page